Bishal Gyawali: Improving patient outcomes is all that matters
Bishal Gyawali, Associate Professor at Queen’s University, shared a tweet by Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals, adding the following on X:
“For a lethal disease like es-SCLC, claiming benefit based on 0.5 month of PFS while OS remains negative….. seriously, where are we going to draw the line?
This is not an isolated example. Recently, I see people congratulating themselves and claiming ‘great win for our patients’ based on embarrassingly dubious marginal results. As long as we continue to celebrate such results, we won’t improve patient outcomes meaningfully despite dozens of celebrations. At the end, improving patient outcomes is all that matters.”
Quoting Amol Akhade’s tweet:
“Can some one tell me why the conclusion of this article published in JTO & JTO CRR dose not mention that OS for this trial is not statistically significant. I can understand that medical writers who wrote the article wanted to hide it for some reasons . But why did editor and reviewers did not ask authors to add that one line in conclusion. Why can’t we have some more honesty in trial publication, at least at editor level?”
Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.
Dr. Amol Akhade is a senior consultant medical oncologist and hemato-oncologist. He has received his super specialization training in hemato-oncology and medical oncology from Tata Memorial Hospital.
He specialises in chemotherapy for hematological cancers as well as solid tumors. He also specialises in allogenic and autologous bone marrow transplant. Currently, he is a Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023